top of page
Contact Us
Contact Us

More case studies

Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted.

Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial

From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days.

CSI's 72-hour Abraxane Rescue Mission

Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant.

CSI’s Expert Delivery of a Global Respiratory Study

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Comparator Sourcing for a Phase II Ophthalmology Study

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Rescuing a Biotech’s Oncology Trial with Lenvima

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

Request

CSI was entrusted with sourcing large quantities of Venetoclax and Azacitidine for a study spanning 17 countries and three continents.


Challenge

The client needed to enroll patients within an extremely short timeframe of 6-months. Additionally, due to the global nature of the study, they also required Certificates of Analysis (CoA), making the feasibility of the request extra challenging.

Solution

Leveraging CSI's strong partnership with AbbVie and generic manufacturers, we were able to cut the study approval time in half and reduce the supply lead time four-fold,  from four months to 4 weeks, including the required documentation. As a result, the client successfully delivered supplies to sites ahead of schedule.

Case Study

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

Request

CSI was entrusted with sourcing large quantities of Venetoclax and Azacitidine for a study spanning 17 countries and three continents.

Challenge

The client faced a tight six-month enrollment deadline and required Certificates of Analysis (CoA) for a complex study.

Solution

CSI utilized its partnerships to halve approval times, reduce supply lead times from four months to four weeks and ensure timely delivery with all required documentation.

Contact us 

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

bottom of page